Psychiatry focuses on diseases characterized by alterations in mood, behavior, cognition and perceptions. Important diseases include schizophrenia, major depressive disorder, bipolar disorder, anxiety disorders and post-traumatic stress disorder. Parexel’s experience includes the use of novel treatments that target substantial unmet medical need, such as negative and cognitive symptoms in schizophrenia and treatment-resistant depression, and conducting studies in both acutely ill and stable patient populations. Our board-certified psychiatrists, in collaboration with biostatisticians and regulatory experts, are always ready to engage in study design optimization, methods to reduce placebo effect and clinical development strategy. Parexel understands the importance of rater training, instream monitoring of data quality and study conduct, and risk mitigation strategies to ensure interpretable study results.
275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300
2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170
© 2000-2022. Parexel International Corporation.